Musculoskeletal disorders and orthopedic conditions

JAMA

Volumn 285, Issue 5, 2001, Pages 619-623

  Boskey, Adele L ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN;

ARTICLE; BONE GROWTH; FRACTURE; GENETIC RISK; HEALTH CARE COST; HOSPITALIZATION; HUMAN; IMPLANTATION; MEDICAL RESEARCH; MUSCULOSKELETAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDICS; PRIORITY JOURNAL;

EID: 0035819472     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.5.619     Document Type: Article

References (82)

1. Launch of the bone and joint decade 2000-2010
2. Reversible extinction of the morphogen in bone matrix by reduction and oxidation of disulfide bonds
3. Anterior lumbar interbody fusion with osteoinductive growth factors
4. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion
5. The family of bone morphogenetic proteins
6. Atomic structure of intracellular amorphous calcium phosphate deposits
7. Discovery! Amorphous calcium phosphate: The contention of bone
8. Differences of bone bonding ability and degradation behaviour in vivo between amorphous calcium phosphate and highly crystalline hydroxyapatite coating
9. Properties and biosynthesis of a vitamin K-dependent calcium binding protein in bone
10. Osteocalcin promoterbased toxic gene therapy for the treatment of osteosarcoma in experimental models
11. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo
12. Marrow-derived progenitor cell injections enhance new bone formation during distraction
13. Series introduction: Stem cells near the century mark
14. Autologous mesenchymal stem cell-mediated repair of tendon
15. The degradation of cartilage proteoglycans by tissue proteinases
16. Cathepsin K and the design of inhibitors of cathepsin K
17. The effect of serum on monolayer cell culture of mammalian articular chondrocytes
18. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee
19. The material science of calcium phosphate ceramics
20. Macroporous calcium phosphate ceramic
21. Are matrix vesicles apoptotic bodies?
22. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase
23. Molecular and cellular mechanisms of estrogen action on the skeleton
24. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant proalpha 1(I) collagen gene
25. Of mice and men: Heritable skeletal disorders
26. The mouse pudgy mutation disrupts Delta homologue DLL3 and initiation of early somite boundaries
27. Mutations in the human Delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis
28. Cultured embryonic bone shafts show osteogenic responses to mechanical loading
29. Osteoporosis and bone functional adaptation
30. Computer- and robot-assisted resection of thalamic astrocytomas in children
31. A review of robotics in surgery
32. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice
33. Promising new agents in osteoporosis
34. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis
35. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
36. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages
37. Rapid expansion of recycling stem cells in cultures of plasticadherent cells from human bone marrow
38. Osteoblast adhesion on biomaterials
39. Clinical results of modular polyethylene insert exchange with retention of total knee arthroplasty components
40. The effect of hospital-type and operating volume on the survival of hip replacements
41. Biological reactions to wear debris in total joint replacement
42. The pathology of total joint arthroplasty, II: Mechanisms of implant failure
43. The economics of preventing revisions in total hip replacement
44. Boneresorbing cytokines in serum of patients with aseptic loosening of hip prostheses
45. Mineral and collagen-binding proteins of fetal calf bone
46. The new partnership of genomics and chemistry for accelerated drug development
47. The biochemistry of bone
48. Beyond the human genome
49. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array
50. Discovery: Osf2/Cbfa1, a master gene of bone formation
51. Tandem repeat of C/EBP binding sites mediates PPARgamma2 gene transcription in glucocorticoid-induced adipocyte differentiation
52. TWIST, a basic helix- loop- helix transcription factor, can regulate the human osteogenic lineage
53. Common molecular pathways in skeletal morphogenesis and repair
54. Drug discovery in the next millennium
55. Combinatorial biosynthesis for new drug discovery
56. Tissue engineering
57. Growing new organs
58. Tissue engineering of ligament and tendon healing
59. GAGaugmented polysaccharide hydrogel: A novel biocompatible and biodegradable material to support chondrogenesis
60. Cartilage tissue engineering: Current limitations and solutions
61. Engineering of osteochondral tissue with bone marrow mesenchymal progenitor cells in a derivatized hyaluronan-gelatin composite sponge
62. Phase-sensitive x-ray imaging
63. Imaging of posttraumatic and soft tissue dysfunction of the elbow
64. Future and new developments in musculoskeletal ultrasound
65. Infrared spectroscopy, microscopy, and microscopic imaging of mineralized tissues
66. Multinuclear solid-state three-dimensional MRI of bone and synthetic calcium phosphates
67. The detection and management of proximal deep venous thrombosis in patients with acute acetabular fractures
68. Orthopaedic applications of gene therapy: From concept to clinic
69. Direct-, fibroblast- and myoblast-mediated gene transfer to the anterior cruciate ligament
70. Human growth hormone transgene expression increases the biomechanical structural properties of mouse vertebrae
71. Gene therapy of arthritis
72. Bioactive factors for bone tissue engineering
73. Nanotechnology in bio/clinical analysis
74. Histomorphometric study on high-strength hyd roxyapatite/poly (L-lactide) composite rods for internal fixation of bone fractures
75. Use of an osteoinductive biomaterial (rhOP1) in healing large segmental bone defects
76. Experimental fetal neurosurgery: Effects of in-utero manipulations on somatosensory evoked potentials
77. Treatable and untreatable risk factors for hip fracture
78. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB
79. Sib pair linkage and association studies between bone mineral density and the interleukin-6 gene locus
80. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene
81. Leptin: Fundamental aspects